Stem Cell Therapy International, Inc. Signs Agreement With Histostem for Worldwide Distribution of SteMixx Cosmetic … (Marketwire)

TAMPA, FL–(Marketwire - December 1, 2009) - Stem Cell Therapy International Inc. ( OTCBB : SCII ) announced that it has signed an agreement with Histostem Ltd. of South Korea (”Histostem”), for the exclusive, worldwide rights to the distribution of the Company’s existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for …
(read the story…)

Related items

• Stem Cell Therapy Featured in The Rose Sheet (Marketwire via Yahoo! Finance)
• Stem Cell Therapy International, Inc. Releases Shareholder Update (Marketwire)
• Stem Cell Therapy International, Inc. Announces Merger With Histostem and Launching of AmStem International, Inc. (Marketwire)
• Stem Cell Therapy International, Inc. Announces Merger With Histostem and Launching of AmStem International, Inc. (dBusinessNews.com)
• Stem Cell Therapy International, Inc. Announces Merger With Histostem and Launching of AmStem International, Inc. (Marketwire via Yahoo! Finance)

Tags: Cell, FL-, histostem, Marketwire, nano, nanotech, nanotechnology, SCII, South Korea, Stem, stem cell therapy, stem cell therapy international, TAMPA, Technology, worldwide rights

This entry was posted on Tuesday, December 1st, 2009 at 10:50 pm and is filed under Business.